(Q33551239)

28 July 2017

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. (English)

1 reference

28 July 2017

1 reference

Jaco Kraan

2

0 references

Stefan Sleijfer

12

object named as

Stefan Sleijfer

1 reference

28 July 2017

Bianca Mostert

1

1 reference

28 July 2017

Joan Bolt-de Vries

3

1 reference

28 July 2017

Petra van der Spoel

4

1 reference

28 July 2017

Anieta M Sieuwerts

5

1 reference

28 July 2017

Mieke Schutte

6

1 reference

28 July 2017

Annemieke M Timmermans

7

1 reference

28 July 2017

Renée Foekens

8

1 reference

28 July 2017

John W M Martens

9

1 reference

28 July 2017

Jan-Willem Gratama

10

1 reference

28 July 2017

John A Foekens

11

1 reference

28 July 2017

language of work or name

English

0 references

publication date

9 April 2010

1 reference

Breast Cancer Research and Treatment

28 July 2017

1 reference

28 July 2017

127

1 reference

28 July 2017

1

1 reference

28 July 2017

33-41

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-010-0879-y

28 July 2017

0 references

cites work

Circulating tumour cell detection on its way to routine diagnostic implementation?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

The prognostic implications of circulating tumor cells in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Subtypes of breast cancer show preferential site of relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Circulating endothelial cells in oncology: pitfalls and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Systematic variation in gene expression patterns in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

Mouse CD146/MCAM is a marker of natural killer cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0879-Y

10.1007/S10549-010-0879-Y

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1038223123

0 references

Fatcat ID

release_exkwm7p7ozbdldiifzu25sbscm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/exkwm7p7ozbdldiifzu25sbscm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference